Syngenta and Novozymes are entering the commercialization phase of the biofungicide Taegro. The two companies originally joined forces in 2012 to develop and market the product, and have now received the first wave of product approvals in Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Honduras, Italy, Netherlands, Romania, Slovenia, Spain, and United Kingdom. Several other approvals are expected across the EU and Latin America during the next 12 months, which will enable multiple product launches in 2020.
Novozymes launched Saphera Fiber, a new lactase enzyme to increase the content of fibers while also reducing sugar in fermented and non-fermented dairy products. At the same time, a recent study testifies that 59% of consumers are more likely to buy dairy products with higher fiber content, and 38% of them are willing to pay more for a higher content of fiber in their dairy products.
Green Plains Inc. and Novozymes signed an exclusive partnership and commercialization agreement for biological solutions in the production of high protein ingredients. The partnership will be aimed at aquaculture, pet food, as well as novel ingredients to be used in the global protein markets.
Novozymes inaugurated its new Innovation Campus in Lyngby, 13 kilometers north of Copenhagen and seven kilometers from its headquarters in Bagsværd. With the location near the Technical University of Denmark, it is Novozymes’ ambition to create a global hub for biotech research.
Now, for the first time, Novozymes’ enzymes are available online through Alibaba’s platform for industrial products, 1688.com.
“We want to be a front runner in providing biological solutions online as well as offline. By partnering with Alibaba, we will get even closer to our end-customers, address local market needs faster and explore new application opportunities,” says Thomas Videbæk, COO and Executive Vice President, Novozymes.
Make a direct impact on the UN’s Sustainable Development Goal 6, aiming at securing universal access to water and sanitation by 2030. This is the scope, when the world’s leading expert in enzymes and microorganisms, Novozymes, and Grundfos, the global leader in advanced pump technologies, enter an open innovation collaboration.
Novozymes launched two new enzymes for the European ethanol market. The two products (Spirizyme® 2.0 T and Spirizyme Ultra T) are part of the Spirizyme T Portfolio, an advanced suite of glucoamylase enzymes with trehalase that deliver yield enhancing activities documented to provide the highest total sugar conversion in the industry.
Novozymes, Novo Nordisk, Kalundborg Forsyning and DONG Energy signed a new 20-year agreement which enables Denmark’s largest coal-fired power station unit, the Asnæs Power Station, to phase out coal and replace it with wood chips. Novozymes sources steam from the power station.
DONG Energy and Bigadan is to build a large-scale biogas plant that will reuse residues from the production facilities of Novozymes and Novo Nordisk in Kalundborg on Zealand. The four companies have just signed an agreement which, from spring 2018, will carry yet another significant contribution to the Danish production of green energy from biogas. The new biogas plant in Kalundborg will convert residues from the factories of Novozymes and Novo Nordisk in Kalundborg to bio natural gas which can be fed directly into the Danish natural gas grid.
Novozymes launched the Spirizyme® T Portfolio, an advanced suite of glucoamylase enzymes with trehalase and other yield enhancing activities that provide the most total sugar conversion in the industry. Trehalase is an enzyme that converts trehalose, a type of sugar that cannot be fermented to ethanol, to glucose, which is easily fermentable.